Showing posts with label post-grant proceedings. Show all posts
Showing posts with label post-grant proceedings. Show all posts

Monday, September 21, 2015

PTAB - Webinar Proposed AIA Trial Rules on Thursday, October 1

Today, PTAB notified it is hosting a free webinar on the proposed AIA trial rules noon to 1 pm ET on Thursday, October 1.

As stated in the notice: "Lead Judge Susan Mitchell will walk through the proposed rule changes followed by a discussion with Lead Judge Mike Tierney and Lead Judge Tom Gianetti about the background, rationale, and implications of the proposed rules. To review the proposed rules in advance, please visit the Federal Register Notice.

On Tuesday, October 6th, AIPLA is holding a companion webinar to address the proposed rule changes from AIA trial practitioners' perspectives, including views from Todd Baker of Oblon and Joe Palys of Paul Hastings. The practitioners will address the practical implications of the rules and how they may alter current AIA trial practice and strategy.

For more information about AIPLA's webinar.

Together, these two programs are designed to address the proposed AIA trial rules from all angles. And at the conclusion of each webinar, viewers will have the opportunity to pose questions to the judges and practitioners. Please attend to participate in the development of the AIA trial rules and share your input."

Webinar Access Information:

Event address for attendees     
 
   
Event number: 994 593 512
Event password: 123456
Audio conference: 1-650-479-3208
Access code: 994 593 512

Copyright © 2015 Robert Moll. All rights reserved.

Friday, September 19, 2014

Intellectual Asset Management - Biggest Impact from Passage of America Invents Act?

Tonight, I suggest reading Intellectual Asset Management's The AIA is 3 today and there’s only one winner for what has been its biggest impact.

As stated by IAM, "Three years ago today President Obama signed the Leahy-Smith America Invents Act into law, heralding the first major shake-up of US patent law in over 50 years. To mark the occasion we thought we would ask a range of people in the market what the AIA's biggest impact has been. The result was unanimous - the new post-grant proceedings at the USPTO’s Patent Trial and Appeal Board (PTAB) has been the game changer."

Copyright © 2014 Robert Moll. All rights reserved.

Thursday, September 18, 2014

USPTO Extends Comment Period on AIA Trials to October 16, 2014

The USPTO is extending the time for public comments on procedures of the America Invents Act (AIA) trials before the Patent Trial and Appeal Board (PTAB).

Any comments must be emailed to trialsrfc2014@uspto.gov by October 16, 2014.

As stated by the USPTO, it "published a request for comments in the Federal Register on June 27, 2014, seeking public comment on all aspects of the new administrative trial proceedings, including the administrative trial proceeding rules and trial practice guide. See Request for Comments on Trial Proceedings Under the America Invents Act Before the Patent Trial and Appeal Board, 79 Fed Reg. 36474-77 (June 27, 2014). The USPTO initially indicated that written comments must be received on or before September 16, 2014. In view of stakeholder requests for additional time to submit comments on the new administrative trial proceedings, the USPTO is now extending the period for public comment until October 16, 2014."

For additional information regarding AIA Trials:

www.uspto.gov/aia_implementation/bpai.jsp

www.uspto.gov/ip/boards/bpai/ptab_trials.jsp.

Copyright © 2014 Robert Moll. All rights reserved.

Friday, February 14, 2014

USPTO - Deputy Director Michelle Lee's Speech to AIPLA on January 30, 2014

On January 30, 2014, USPTO Deputy Director Michelle Lee delivered a state of the agency speech to a gathering at the 2014 Mid-Winter meeting of the American Intellectual Property Law Association (AIPLA), which is the largest organization of patent attorneys. I just read the speech, which is impressive and gives the USPTO's plans.

Copyright © 2014 Robert Moll. All rights reserved.

Thursday, January 16, 2014

US Supreme Court Certiorari - SAP America v. Versata Software - Software Patent Infringement, Expert Testimony, and Denial of Stay of Litigation Based on PTAB Invalidity Decision

Today, Mary Pat Dwyer of the SCOTUS Blog stated the petition of the day relates to the Federal Circuit's decision in SAP America, Inc. v. Versata Software, Inc.

SAP, the petitioner and defendant below, frame the issue as follows: (1) Whether a computer software manufacturer may be liable for direct infringement of a patent drawn to computer instructions where the software, as shipped, does not contain sufficient instructions to perform the claimed operations; (2) whether flaws in an expert’s methodology may be raised as part of a challenge to the sufficiency of the evidence or only to the testimony’s admissibility; and (3) whether a patent infringement action should be stayed where the Patent Trial and Appeal Board (PTAB) has declared invalid all patent claims at issue in the infringement action and the defendant, which sought such review at the first opportunity, might otherwise be compelled to pay an enormous damages judgment and be subjected to a permanent injunction on the basis of the invalid claims.

Versata Software, the respondent and patent owner, frame the issue as follows: (1) Whether both courts below erred in ruling that the trial record supported the jury’s factual determination that SAP’s software and source code, as shipped, met every limitation of the asserted patent claims without modification by the customer; (2) whether the Federal Circuit properly declined to address challenges to the expert’s methodology insofar as they were framed as challenges to admissibility where SAP conceded it was not challenging the testimony’s admissibility on methodological grounds and had waived any such challenge below; and (3) whether the Federal Circuit was required to stay this patent infringement action under the Leahy-Smith America Invents Act where SAP did not seek a stay until after the Federal Circuit had issued its opinion on the merits, and the four statutory factors each weigh against the requested stay.

Whether or not the Supreme Court hears this case, the message I am hearing is delay in requesting a stay may negate a major benefit (e.g., erasing $330M in damages) of a PTAB decision holding the patent invalid. 

See the papers, orders, and proceedings at SCOTUS blog page.

Copyright © 2014 Robert Moll. All rights reserved.

Tuesday, January 7, 2014

Ashby Jones of WSJ - Law 2014: Patents Likely to Keep Top Billing in the News

Mr. Ashby Jones predicts what patent issues (e.g., US patent reform legislation, the Supreme Court case on software patent eligibility, Alice v. CLS Bank, and rise of the Patent Trial and Appeal Board) are likely in 2014 in the WSJ article Law 2014: Patents Likely to Keep Top Billing in the News.

Copyright © 2014 Robert Moll. All rights reserved.

Wednesday, May 29, 2013

David Kappos - Investing in America's Future Through Innovation

Former USPTO Director David Kappos, now a partner at Cravath Swaine & Moore, LLP, recently wrote an interesting article in The Stanford Technology Law Review: Investing in America's Future Through Innovation: How the Debate over the Smartphone Patent Wars (Re)Raises Issues at the Foundation of Long-Term Incentive Systems.

Copyright © 2013 Robert Moll. All rights reserved.

Tuesday, December 4, 2012

America Invents Act - Proposed Bill H.R. 6621 Technical Amendment to AIA

On November 30, Congressman Smith introduced a bill H.R. 6621 to change language in the America Invents Act (AIA).

Some refer to it as a "technical amendment" that corrects errors in the AIA. However, it buries a provision that will eliminate many if not all pre-GATT applications (i.e., about 200 applications filed before June 7, 1995) if they fail to issue as US patents within one year of the bill's enactment. It does this by rendering them ineligible for a patent term that runs 17 years from grant date. Instead their patent term would only run 20 years from filing date. Even if only 0.02% of all pending applications (e.g., 1.2M) are affected, it sounds like some want to eliminate or greatly reduce their patent terms. Do the math!

On the other hand, it doesn't seek to change the estoppel standard for post grant review, which is wise given the arguments raised in its favor. See e.g., Robert L. Stoll, Maintaining Post-Grant Review Estoppel in the America Invents Act: A Call for Legislative Restraint.

Copyright © 2012 Robert Moll. All rights reserved.

Thursday, November 29, 2012

American Invents Act Driving More Provisional Application Filings

Professor Dennis Crouch's Provisional Patent Applications as a Flash in the Pan: Many are Filed and Many are Abandoned contains a graph showing provisionals have steadily increased from 1995 to 2012. In FY 2012, we are up to 160,000 filings! In a smaller study he found that 35% of provisionals do not include a single claim. Claims aren't required so this is not surprising, but it is surprising that 15% of the provisionals are a stack of presentation materials (e.g., PowerPoint?) since a provisional must enable the claimed invention. See my articles for an explanation:

The Benefits of Provisional Applications: Slip, Sliding Away

Leader Technologies v. FaceBook - Provisional Fails to Save Patent from On Sale Bar and Public Use

Whether or not we love or hate provisionals, we should expect the annual filing rates to rise. The AIA first inventor to file provisions contained in 35 USC 102 and effective on March 16, 2013 retain a one year grace period for inventor (and inventor derived) disclosures, but do not expressly shield a pre-filing offer for sale, a public use, or a publication that cannot be traced back to one of the inventors.

Harold Wegner says the scope of the AIA grace period is an open question. See Wegner, The 2011 Patent Law: "Leahy-Smith maintains the concept of a one year grace period for inventor's pre-filing activities but defines the grace period as limited to the applicant's 'disclosures' of the invention, making it an open question whether a secret commercialization or other 'public use' or 'on sale' events fall under the grace period because they may not constitute 'disclosures' of the invention."

For now it's safer to take a narrow view of the grace period. Thus, a provisional or a nonprovisional satisfying 35 USC 112 must be filed before an offer for sale or public use of the invention. If an examiner assumes a nonprovisional is entitled to the provisional filing date, a sketchy provisional may as well have a flag: "litigators here is a promising date range for prior art to invalidate a patent-- between the provisional and the nonprovisional filing dates" (i.e., when the technology is most developed and time-wise qualified). Many provisionals do not satisfy 35 USC 112 and nonprovisionals depending on them for priority may find the effective filing date is the nonprovisional filing date.

The fact more than half of provisionals are abandoned without the filing of a nonprovisional is consistent with the PTO's stated purpose: to give inventors one year to explore whether the invention has commercial prospects before filing a more expensive nonprovisional. The AIPLA Report of the Economic Survey 2011 says a typical charge for a provisional is $3,500, while the typical charge for a nonprovisional is $7,000 - $12,000. I see the cost savings, but given the price difference note it isn't realistic to expect both are equal to the task of satisfying 35 USC 112.

Copyright © 2012 Robert Moll. All rights reserved.

Tuesday, November 27, 2012

Oracle v. Google - Patent and Copyright Cases - Groklaw's Timeline and Court Papers

Wikipedia says "Groklaw is an award-winning website covering legal news of interest to the free and open source software community." Its slogan: "digging for the truth" is accurate in that Groklaw does a great job of posting legal documents that would be typically not found inexpensively; it seems less accurate if it means the opinions of a blog that functions as a bully pulpit for paralegal Pamela Jones ("PJ") to articulate the rightness of the free and open source software communities opposition to intellectual property and particularly software patents.

Still Groklaw is an excellent resource for tech people having to deal with intellectual property law. For example, I spent many evenings reading about the Oracle v. Google patent and copyright trials then news coverage vanished after Oracle lost its case. Thus, I appreciate Groklaw's effort in doubling back and posting the complete trial transcripts: Oracle v. Google Timeline when it is not a hot topic. There is lot to learn from them.

The trial transcripts suggest why billing by the hour is so profitable for litigation attorneys: "If you are paying by the hour, I see where I can file another paper to advance your cause." Joking aside, they don't have much choice. The Federal Rules of Civil Procedure and modern patent litigation dictate a number of the filings. If an attorney files a motion, the opposing litigator must reply to avoid conceding unless the client authorizes it.  And when you have mobile computing at stake, and Oracle's and Google's financial resources, the massive transcripts are inevitable and indicates why this litigation was so expensive despite reexamination eliminating all but two Oracle patents.

Updated November 30, 2012: FOSS Patents reports: Oracle's appeal of ruling in Google/Java case focuses entirely on copyright, drop patents

Copyright © 2012 Robert Moll. All rights reserved.

Wednesday, November 21, 2012

Director Kappos: An Examination of Software Patents Speech on Nov 20, 2012

Under Secretary of Commerce for IP and Director of the USPTO, David Kappos strongly defended valid software patents in a keynote address at the Center for American Progress on November 20, 2012.

Director Kappos' speech: An Examination of Software Patents sets forth a convincing case for software patenting and the U.S. patent system. This speech should be considered by all who think or hear the U.S. patent system is broken.

Copyright © 2012 Robert Moll. All rights reserved.

Saturday, October 20, 2012

Belkin International v. Kappos - Inter Partes Reexamination - Scope Limited to Prior Art Raising the Substantial New Question of Patentability

On September 16, 2012, the America Invents Act ended the ability to request inter partes reexamination.

However, inter partes reexamination requests filed prior to September 16 could remain for years. So it is worth looking at In Belkin v. Kappos and Optimum Path. In this case, the Federal Circuit affirmed the Board cannot consider prior art references that don't raise a substantial new question of patentability.

A policy limiting the scope of reexamination may seem harsh, but you have to consider the PTO's burden in examining all the arguments and prior art in requests for inter partes reexamination even when they don't raise a substantial new question of patentability. I reviewed one request that was over 600 pages!

Here's what the Federal Circuit had to say:

If the Director determines that any references does not raise a substantial new question of patentability, one must petition the Director to review the determination pursuant to 37 C.F.C. § 1.927. If this is not done that decision becomes final and nonappealable, and renders those issues beyond the scope of the reexamination.

Belkin requested inter partes reexamination of U.S. Patent No. 7,035,281 stating four prior art references raised new questions of patentability regarding claims 1-32. The Director determined the first three references did not raise a substantial new question of patentability, but the fourth reference did with respect to claims 1-3 and 8-10. Thus, the Director ordered reexamination of claims 1-3 and 8-10.

The Director denied Belkin's petition to review the denial of reexamination of claims 4-7 and 11-32. Belkin for reasons stated below, did not, however, file a petition to review the determination that the first three prior art references failed to raise substantial new questions of patentability concerning claims 1-3 and 8-10.

The examiner issued an action closing prosecution in the reexamination addressing only Belkin's proposed rejection of claims 1-3 and 8-10 as anticipated by the fourth reference and a right of appeal notice issued addressing only the fourth reference. Belkin appealed to the Board to challenge the examiner's not rejecting claims based on the first three references.

The Board determined that it lacked jurisdiction to decide whether a substantial new question of patentability existed regarding the first three references since that determination is non-appealable under 35 U.S.C. § 312(c). The Board held that it had no final decision on patentability and nothing to appeal regarding the three references. The Board affirmed the examiner's regarding the fourth reference. On rehearing, the Board declined to modify its decision and noted Belkin had not petitioned under 37 C.F.R. § 1.927 to review the Director's determination that there was no substantial new question of patentability for the issues based on the three references regarding claims 1-3 and 8-10.

Belkin unsuccessfully argued the Board has jurisdiction to consider the first three prior art references because once a substantial new question of patentability affecting a claim is found, all prior art must be considered including prior art found previously not to raise a substantial new question of patentability.

The Director responded 35 USC § 312(c) bars the Board from considering prior art not found to raise a substantial new question of patentability even if a substantial new question of patentability was found with respect to other references. The Director argued reexamination is limited to resolve the substantial new question of patentability, not questions raised by the requester that have been determined not to rise to that level. As only one reference raised a substantial new question of patentability, the Director argued the reexamination was limited to that question.

The Federal Circuit agreed and stated such an issue is nonappealable. At the outset, an inter partes reexamination is a two-step process. First, the Director must determine whether a substantial new question of patentability affecting any claim of the patent is raised by the request under § 311, with or without consideration of other patents or printed publications. 35 U.S.C. § 312(a). The statute is clear that decision is final and nonappealable. § 312(c).

The Federal Circuit noted the statute requires the Director order reexamination for resolution of the substantial new question of patentability found by the Director under § 312(a). The statute thus requires that an issue must raise a "substantial new" question of patentability with respect to cited prior art before it can be considered during inter partes reexamination. And an issue that has been determined to raise a substantial new question of patentability with respect to certain other prior art cannot be considered by the examiner and ultimately the Board. Instead if a requester disagrees with the decision that no substantial new question of patentability has been raised, 37 C.F.R. § 1.927 only permits the requester to petition the Director for review of that decision. Belkin didn't file a petition with respect to claims 1-3 and 8-10.

The Federal Circuit held:

Inter partes reexamination is not totally limited to those issues suggested by the requester that present a substantial new question of patentability. Indeed, the PTO may make any new rejection, as long as that rejection also meets the substantial new question of patentability requirement. See 35 U.S.C. § 303(a) ("On his own initiative, and any time, the Director may determine whether a substantial new question of patentability is raised by patents and publications discovered by him . . .."). Thus, the scope of reexamination may encompass those issues that raise a substantial new question of patentability, whether proposed by the requester or the Director, but, unless it is raised by the Director on his own initiative, it only includes issues of patentability raised in the request under § 311 that the Director has determined raise such an issue. It otherwise may not include other prior art than what constituted the basis of the Director's determination of a substantial question of patentability.

Belkin unsuccessfully argued that such a result is inconsistent with the appeals statutes, 35 U.S.C. §§ 134(c) and 315(b), and regulations such as 37 C.F.R. § 41.61(a)(2). Those statutes grant rights to the requester to appeal a "final decision. . . favorable to the patentability of any . . . claim." §§ 134(c), 315(b). Similarly, § 41.61(a)(2) specifically allows the requester to appeal "any final decision favorable to the patentability, including any final determination not to make a proposed rejection, of any . . . claim." Id. Belkin argues that the examiner's decision not to reject claims 1-3 and 8-10 based on the issues determined not to raise a substantial new question was a decision favorable to patentability.

Belkin argued it did not petition for review of claims 1-3 and 8-10 because the Manual of Patent Examination and Procedure ("MPEP") § 2648 states: No petition may be filed requesting review of a decision granting a request for reexamination even if the decision grants the request as to a specific claim for reasons other than those advanced by the third party requester. No right to review exists as to that claim, because it will be reexamined in view of all prior art during the reexamination under 37 CFR 1.937.

The Federal Circuit responded that provision does not discuss the preclusive effect of a determination that an issue does not raise a substantial new question of patentability. Instead, MPEP § 2648 states the uncontroversial proposition that no petition may be filed to review a decision granting a request for reexamination.

Belkin also argued that 37 C.F.R. § 1.104 supports its interpretation because that regulation requires the examiner to make a "thorough investigation of the available prior art" during reexamination. The Federal Circuit maintained section 1.104 wouldn't help Belkin as the "available prior art" is only that which the Director has indicated constitutes a substantial new question of patentability.

The Federal Circuit noted a reference to "all prior art" in the MPEP or the regulations cannot trump the statute. Statutes rank higher than regulations, which rank higher than the MPEP.

Belkin relies on a decision of the Director denying a petition for review of the denial of four substantial new questions of patentability relating to a different patent to assert that it could not have petitioned the Director concerning his decision on the substantial question of patentability. Decision Expunging Petitions, In re Schwindt, Reexamination Control No. 95/001,743 (Mar. 5, 2012) (J.A. 1840-43). Belkin notes that the decision denied the petition because reexamination was ordered for the same claims on a different ground than proposed by the requester pursuant to MPEP § 2648. However inconsistent that decision may or may not be with the Director's current position, it must yield to the statute, which denies appealability of the Director's decisions on substantial questions.

Belkin raised concerns a third-party requester in an inter partes reexamination is estopped from later asserting the invalidity of any claim "finally determined to be valid and patentable on any ground which the thirdparty requester raised or could have raised" during the reexamination. Belkin argues that once reexamination has been granted, the requester must put forward all eligible prior art or face that estoppel. Belkin's concerns are unwarranted.

The Federal Circuit replied the estoppel was not before it. As Belkin merely asserted that the three references raised substantial new questions of patentability as to claims 1-3 and 8-10— which the Director rejected—Belkin's arguments regarding estoppel are thus not persuasive.

The Federal Circuit concluded Belkin should have petitioned the Director to review the determination that the arguments relying on the other references did not raise a substantial new question of patentability pursuant to 37 C.F.C. § 1.927. Belkin didn't and the decision became final and nonappealable, rendering those issues beyond the scope of the reexamination. Accordingly, it affirmed the Board.

The Federal Circuit also cautioned that America Invents Act amended the inter partes reexamination provisions and the request for inter partes reexamination in this case was filed before the date of enactment, September 16, 2011. Thus, the Federal Circuit expressed no opinion on the applicability of the AIA to the case, and did not reach the issue of what prior art references the PTO may or may not consider during reexamination in response to an amended or substituted claim.

Copyright © 2012 Robert Moll. All rights reserved.

Thursday, September 27, 2012

Ariosa Diagnostics v. Isis Innovation Limited - Incomplete Petition for Inter Partes Review - No Filing Date Granted!

Part of being a patent lawyer is understanding how the new PTO rules will be implemented. Of course with the new post grant proceedings available on September 16, 2012, we have many new rules plus a new decision-making body, the Patent Trial and Appeal Board (PTAB).

How will PTAB interpret the new rules relating to inter partes review?

We only have one decision on what is required for a petition to obtain a filing date, but for what it is worth Ariosa Diagnostics v. Isis Innovation Limited suggests the PTAB can play hardball. 

After Ariosa Diagnostics (Petitioner) filed a petition for inter partes review of U.S Patent No. 6,258,540, owned by Isis Innovation Limited, the PTAB decided the petition would not be granted a filing date because it had the following deficiencies: (1) Exhibits 1011, 1012, 1028, and 1030 didn't match the Exhibit List; (2) the Exhibit List stated Exhibits 1029 and 1032 were "Intentionally Left Blank," but they weren't blank (Exhibit "1029" was a duplicate of Exhibit 1027 and Exhibit "1032" was a duplicate of Exhibit 1031); (3) Petitioner's addresses (e-mail, postal and hand delivery) and phone were missing; and (4) the Petition failed to clearly designate lead and back-up counsel.

OK. The Ariosa attorneys did not submit a "perfect" petition. 37 CFR 42.106 says to be granted a filing date the petition for inter partes review must include the required inter partes fee (37 CFR 42.103), the petitioner must serve the petition and exhibits on the patent owner (37 CFR 42.105), the content of the petition must identity of the challenged claims, the basis for the challenge the evidence supporting the challenge, and a certification that the petititioner is not barred or estopped from filing the petition (37 CFR 42.104).

The PTAB decision doesn't refer to 37 CFR 42.105, but it appears the PTAB may consider the mixed up exhibits and list a failure to "serve exhibits" on the patent owner. I think people will now be triple checking their exhibit lists, exhibits, and other petition papers to ensure getting a filing date.

One last question: If the Petitioner's addresses (e-mail, postal and hand delivery) and phone are missing, did they get the Notice of Incomplete Petition?

Copyright © 2012 Robert Moll. All rights reserved.

Wednesday, September 5, 2012

America Invents Acts - Electronic Filing System for Post-Grant Procedures - USPTO Free Seminar September 6, 2012

If you plan to file papers in the new post-grant procedures (e.g., post-grant review, inter partes review, and the transitional program for business methods), you may want to attend the Patent and Trial and Appeal Board's seminar. The Board plans to preview how to file papers using the new electronic file system.

The USPTO will preview:
  • An overview of the new trials available on September 16, 2012
  • An overview of the Patent Trial and Appeal Board home page resources
  • A panel presentation on the Patent Review Processing System (PRPS) filing and record management system
  • A Q&A session
This seminar will be a free live web seminar: 10 am - noon ET, September 6, 2012.

The USPTO press release: PRPS Public Preview - Patent Review Processing System Preview gives the details on how to sign up.

Copyright © 2012 Robert Moll. All rights reserved.

Saturday, August 18, 2012

America Invents Act - USPTO Publishes Final Rules Post-Grant Procedures

On August 14, 2012, the USPTO published its final rules on post-grant procedures for challenging US Patents. If you want to learn more about the rules governing post-grant challenges in the PTO, I suggest starting with this article:

PTO's Final Rules for Post-Grant Challenges Show Little Change From Original Proposals - Bloomberg BNA

Bloomberg BNA published the rules (here), which become effective on September 16, 2012.

Copyright © 2012 Robert Moll. All rights reserved.

Saturday, June 23, 2012

A Guide to the Legislative History of the America Invents Act (AIA)

If you are interested in the legislative history of the America Invents Act (AIA), I recommend reading Joe Matal's A Guide to the Legislative History of the America Invents Act: Part I of II and Part II of II. Here are links to download Part I and Part II of the Guide. This article should be helpful to applicants for US patents and parties seeking to challenge issued US patents in the PTO.

As a brief summary, Part I describes the legislative history and origins of the first-to-file system and the modifications to 35 USC 102 (novelty and statutory bars), 35 USC 103 (obviousness), 35 USC 115 (inventor's declaration), 35 USC 122 (confidential status and publication of applications), and 35 USC 135 (derivation).

Part II describes the legislative history and origins of the new laws that apply to US patents. Thus, it describes the post-grant procedures, inter partes proceedings, supplemental examination, business method patent review, the new defense of prior commercial use, partial repeal of the best mode, virtual and false marking, advice of counsel, court jurisdiction, PTO funding, and rules for patent term extensions.

Although the article should prove useful, legislative history can be misleading. Indeed, the Supreme Court  has warned against relying on legislative statements not anchored in the text of the statute. First, the statements may not pertain to a law that passed. It is also difficult to identify who drafted the law. Given we don't know who drafts the laws, how do we assign weight to the statements of various members of Congress? Also the legislative history of the AIA is lengthy as it stretches from 2005 to 2011. Nonetheless, organizing the legislative history of the AIA is a major undertaking so the article is a welcome start.

Copyright © 2012 Robert Moll. All rights reserved.

Sunday, May 20, 2012

Kappos v. Hyatt - 35 USC § 145 Proceedings Allow New Evidence Beyond Record in PTO

In Kappos v. Hyattt, 132 S.Ct. 1690 (2012), the Supreme Court gave a favorable standard for patent appellants that need to introduce evidence after losing on appeal to the Board of Patent Appeals and Interferences (Board).

If the Board affirms the examiner's rejections under 35 USC  §131 a patent applicant has two options: (1) a direct appeal to the Federal Circuit under 35 USC §141; or (2) an action against the PTO Director in federal district court under 35 USC §145. One can also abandon the application or file a continuation, but one unwilling to narrow the rejected claims in the continuation should not expect much.

Harold Wegner notes that a direct appeal to the Federal Circuit is a long shot, because an appellant will not be able to challenge the facts if there is "substantial evidence" to support the facts, which means the Federal Circuit will not reverse the Board’s decision on facts if a reasonable mind might accept the evidence as adequate to support a conclusion. For example, this standard would apply to the Board's factual findings underlying a legal conclusion of obviousness.

In Kappos v. Hyatt, the Supreme Court found no limits on applicants ability to introduce new evidence in a 35 USC § 145 proceeding beyond the limits set forth in the Federal Rules of Evidence and the Federal Rules of Civil Procedure. Further, Supreme Court held if new evidence is presented on a question of fact, the district court must make de novo (i.e., anew) findings that consider the new evidence and the USPTO record.

Companies are stretching to keep legal costs low. The majority had reasoned that "purposely concealed evidence" in the PTO was unlikely since it would undermine the case. However, given today's tight budgets, some may want seek to not file all of the favorable evidence such as that contained in declarations to avoid the expense and risk. However, holding back some favorable evidence may risk some court holding it was "purposely concealing evidence" rather than "reasonable management of legal costs" and that the evidence should not have been admitted by the district court.

In the past, appellants rarely filed a 35 USC § 145 action. Instead, most appealed directly to the Federal Circuit. Now I expect Kappos v. Hyatt will encourage more to file a 35 USC 145 action when (1) a continuation is unlikely to result in claim coverage that properly protects the invention, and (2) appellants need to introduce new evidence in the record in support of patentability.

Finally, I should note those losing an AIA post-grant proceeding at the Board will need to appeal directly to the Federal Circuit and will not be allowed to file a 35 USC § 145 actions

Copyright © 2012 Robert Moll. All rights reserved.